ASTRAZENECA AB PATENTS FACING OPPOSITIONS
Top patents of ASTRAZENECA AB facing oppositions at the European Patent Office (EPO)
Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
EP2056832B1 |
22 Mar, 2017
|
Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin Derivate
|
Aug, 2027
|
3
| |
EP3769781B1 |
19 Apr, 2023
|
Stable Anti-Ifnar1 Formulation
|
Aug, 2036
|
1
| |
EP3142661B1 |
06 Oct, 2021
|
Method For Suppressing Glucagon Secretion Of An Sglt2 Inhibitor
|
May, 2035
|
1
| |